Evaluation of Mycobacteria Infection Prevalence and Optimization of the Identification Process in North Sardinia, Italy

Overview

Journal Microbiol Spectr

Specialty Microbiology

Date 2023 Dec 7

PMID 38059624

Authors

Xiang Chen

Leonardo Antonio Sechi

Paola Molicotti

Affiliations

Soon will be listed here.

Abstract

Mycobacterial infection is a major threat to public health worldwide. Accurate identification of infected species and drug resistance detection are critical factors in treatment. We focused on shortening the turn-around time of identifying mycobacteria species and antibiotic resistance tests.

Citing Articles

Case report: Difficult diagnosis of infection in patients after allogeneic hematopoietic stem cell transplantation: two case reports and a literature review.

Liu Z, Cai D, Su N Front Oncol. 2024; 14:1283320.

PMID: 38863639 PMC: 11165128. DOI: 10.3389/fonc.2024.1283320.

References

Balada-Llasat J, Kamboj K, Pancholi P . Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry in the clinical laboratory. J Clin Microbiol. 2013; 51(9):2875-9. PMC: 3754642. DOI: 10.1128/JCM.00819-13. View

Peng J, Song J, Wang F, Zuo P, Lu Y, Liu W . Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting. Front Cell Infect Microbiol. 2021; 11:650163. PMC: 8012509. DOI: 10.3389/fcimb.2021.650163. View

Falkinham 3rd J . Environmental sources of nontuberculous mycobacteria. Clin Chest Med. 2015; 36(1):35-41. DOI: 10.1016/j.ccm.2014.10.003. View

Sulis G, Pai M . Isoniazid-resistant tuberculosis: A problem we can no longer ignore. PLoS Med. 2020; 17(1):e1003023. PMC: 6974036. DOI: 10.1371/journal.pmed.1003023. View

Li J, Yang T, Hong C, Yang Z, Wu L, Gao Q . Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis. Microbiol Spectr. 2022; 10(3):e0271421. PMC: 9241708. DOI: 10.1128/spectrum.02714-21. View

Portelli S, Myung Y, Furnham N, Vedithi S, Pires D, Ascher D . Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches. Sci Rep. 2020; 10(1):18120. PMC: 7581776. DOI: 10.1038/s41598-020-74648-y. View

Rodriguez-Temporal D, Rodriguez-Sanchez B, Alcaide F . Evaluation of MALDI Biotyper Interpretation Criteria for Accurate Identification of Nontuberculous Mycobacteria. J Clin Microbiol. 2020; 58(10). PMC: 7512167. DOI: 10.1128/JCM.01103-20. View

Machado D, Couto I, Viveiros M . Advances in the molecular diagnosis of tuberculosis: From probes to genomes. Infect Genet Evol. 2018; 72:93-112. DOI: 10.1016/j.meegid.2018.11.021. View

Dean A, Zignol M, Cabibbe A, Falzon D, Glaziou P, Cirillo D . Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data. PLoS Med. 2020; 17(1):e1003008. PMC: 6974034. DOI: 10.1371/journal.pmed.1003008. View

10.

Lempens P, Meehan C, Vandelannoote K, Fissette K, de Rijk P, Van Deun A . Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. Sci Rep. 2018; 8(1):3246. PMC: 5818527. DOI: 10.1038/s41598-018-21378-x. View

11.

Li X, Li G, Yang J, Jin G, Shao Y, Li Y . Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2022; 23(20). PMC: 9604410. DOI: 10.3390/ijms232012443. View

12.

Luukinen B, Vuento R, Hirvonen J . Evaluation of a semi-automated Seegene PCR workflow with MTB, MDR, and NTM detection for rapid screening of tuberculosis in a low-prevalence setting. APMIS. 2020; 128(5):406-413. DOI: 10.1111/apm.13040. View

13.

Morimoto K, Iwai K, Uchimura K, Okumura M, Yoshiyama T, Yoshimori K . A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc. 2013; 11(1):1-8. DOI: 10.1513/AnnalsATS.201303-067OC. View

14.

van Ingen J, Bendien S, de Lange W, Hoefsloot W, Dekhuijzen P, Boeree M . Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009; 64(6):502-6. DOI: 10.1136/thx.2008.110957. View

15.

van Ingen J, Obradovic M, Hassan M, Lesher B, Hart E, Chatterjee A . Nontuberculous mycobacterial lung disease caused by complex - disease burden, unmet needs, and advances in treatment developments. Expert Rev Respir Med. 2021; 15(11):1387-1401. DOI: 10.1080/17476348.2021.1987891. View

16.

Horne D, Kohli M, Zifodya J, Schiller I, Dendukuri N, Tollefson D . Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019; 6:CD009593. PMC: 6555588. DOI: 10.1002/14651858.CD009593.pub4. View

17.

Gill L, Dominic C, Tiberi S . Atypical mycobacterial infections - management and when to treat. Curr Opin Pulm Med. 2021; 27(3):216-223. DOI: 10.1097/MCP.0000000000000764. View

18.

Xu Y, Liang B, Du C, Tian X, Cai X, Hou Y . Rapid Identification of Clinically Relevant Species by Multicolor Melting Curve Analysis. J Clin Microbiol. 2018; 57(1). PMC: 6322455. DOI: 10.1128/JCM.01096-18. View

19.

To K, Cao R, Yegiazaryan A, Owens J, Venketaraman V . General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: and . J Clin Med. 2020; 9(8). PMC: 7463534. DOI: 10.3390/jcm9082541. View

20.

Daley C, Iaccarino J, Lange C, Cambau E, Wallace Jr R, Andrejak C . Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020; 56(1). PMC: 8375621. DOI: 10.1183/13993003.00535-2020. View